FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017121844> ?p ?o ?g. }

• W2017121844 endingPage "614" @default.
• W2017121844 startingPage "609" @default.
• W2017121844 abstract "ObjectivesThe value of alternative autogenous venous conduits for treating critical limb ischaemia (CLI) with infragenicular bypass surgery is well established. In this study, the results of using arm veins as alternative conduits for treating CLI over a 15-year period have been evaluated.MethodsThis was a retrospective study. Between 1991 and 2005. 120 infragenicular bypasses using arm vein conduits (AVCs) were performed in 120 patients. CLI was the main indication (87.5%) for the procedures. The indications for using arm veins were inadequacy or absence of the ipsilateral greater saphenous vein (GSV). Survival, limb salvage, and patency rates were calculated using the Kaplan–Meier method.ResultsThere was a predominance of male gender (65%), and the group mean age was 68.1 ± 8.3 years. The mean follow-up period was 29.6 ± 26.3 months. The operative mortality (30 days) rate was 7.5%. The main alternative conduit was non-spliced cephalic vein (37.5%). Composite grafts included GSV + AVC (45.2%), AVC + AVC (43.3%) and small saphenous vein + AVC (11.5%). The 5-year primary and secondary patency (SP) rates were 45.2 ± 5.6% and 56.5 ± 5.0%, respectively. The 5-year SP rate was greatest when using non-spliced cephalic vein (65.8 ± 7.6%), but there was no difference in cumulative patency between spliced and non-spliced veins (49.5 ± 8.0% vs. 61.2 ± 6.4%; p = 0.501). The 5-year limb salvage and survival rates were 70.6 ± 5.9% and 59.6 ± 5.8%, respectively.ConclusionsThe favourable long term results of secondary patency and limb salvage rates encourage the use of arm veins as alternative conduits for infragenicular bypass surgery. The value of alternative autogenous venous conduits for treating critical limb ischaemia (CLI) with infragenicular bypass surgery is well established. In this study, the results of using arm veins as alternative conduits for treating CLI over a 15-year period have been evaluated. This was a retrospective study. Between 1991 and 2005. 120 infragenicular bypasses using arm vein conduits (AVCs) were performed in 120 patients. CLI was the main indication (87.5%) for the procedures. The indications for using arm veins were inadequacy or absence of the ipsilateral greater saphenous vein (GSV). Survival, limb salvage, and patency rates were calculated using the Kaplan–Meier method. There was a predominance of male gender (65%), and the group mean age was 68.1 ± 8.3 years. The mean follow-up period was 29.6 ± 26.3 months. The operative mortality (30 days) rate was 7.5%. The main alternative conduit was non-spliced cephalic vein (37.5%). Composite grafts included GSV + AVC (45.2%), AVC + AVC (43.3%) and small saphenous vein + AVC (11.5%). The 5-year primary and secondary patency (SP) rates were 45.2 ± 5.6% and 56.5 ± 5.0%, respectively. The 5-year SP rate was greatest when using non-spliced cephalic vein (65.8 ± 7.6%), but there was no difference in cumulative patency between spliced and non-spliced veins (49.5 ± 8.0% vs. 61.2 ± 6.4%; p = 0.501). The 5-year limb salvage and survival rates were 70.6 ± 5.9% and 59.6 ± 5.8%, respectively. The favourable long term results of secondary patency and limb salvage rates encourage the use of arm veins as alternative conduits for infragenicular bypass surgery." @default.
• W2017121844 created "2016-06-24" @default.
• W2017121844 creator A5024466338 @default.
• W2017121844 creator A5035481055 @default.
• W2017121844 creator A5039108879 @default.
• W2017121844 creator A5046463808 @default.
• W2017121844 creator A5047655376 @default.
• W2017121844 creator A5049492908 @default.
• W2017121844 creator A5051058664 @default.
• W2017121844 creator A5055865734 @default.
• W2017121844 date "2014-06-01" @default.
• W2017121844 modified "2023-09-26" @default.
• W2017121844 title "Arm Vein as an Alternative Autogenous Conduit for Infragenicular Bypass in the Treatment of Critical Limb Ischaemia: A 15 Year Experience" @default.
• W2017121844 cites W1968855271 @default.
• W2017121844 cites W1985193197 @default.
• W2017121844 cites W1985836149 @default.
• W2017121844 cites W1985895469 @default.
• W2017121844 cites W1987177254 @default.
• W2017121844 cites W1988939866 @default.
• W2017121844 cites W1999744917 @default.
• W2017121844 cites W2000755267 @default.
• W2017121844 cites W2016056120 @default.
• W2017121844 cites W2034225723 @default.
• W2017121844 cites W2035956275 @default.
• W2017121844 cites W2043517681 @default.
• W2017121844 cites W2043884373 @default.
• W2017121844 cites W2049456065 @default.
• W2017121844 cites W2054031393 @default.
• W2017121844 cites W2055541728 @default.
• W2017121844 cites W2060619011 @default.
• W2017121844 cites W2062327840 @default.
• W2017121844 cites W2063524432 @default.
• W2017121844 cites W2064224103 @default.
• W2017121844 cites W2064909473 @default.
• W2017121844 cites W2074741093 @default.
• W2017121844 cites W2077622739 @default.
• W2017121844 cites W2082255460 @default.
• W2017121844 cites W2111670675 @default.
• W2017121844 cites W2164799868 @default.
• W2017121844 cites W2415959316 @default.
• W2017121844 cites W4319705897 @default.
• W2017121844 doi "https://doi.org/10.1016/j.ejvs.2014.01.019" @default.
• W2017121844 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24613136" @default.
• W2017121844 hasPublicationYear "2014" @default.
• W2017121844 type Work @default.
• W2017121844 sameAs 2017121844 @default.
• W2017121844 citedByCount "34" @default.
• W2017121844 countsByYear W20171218442015 @default.
• W2017121844 countsByYear W20171218442016 @default.
• W2017121844 countsByYear W20171218442017 @default.
• W2017121844 countsByYear W20171218442018 @default.
• W2017121844 countsByYear W20171218442019 @default.
• W2017121844 countsByYear W20171218442020 @default.
• W2017121844 countsByYear W20171218442021 @default.
• W2017121844 countsByYear W20171218442022 @default.
• W2017121844 countsByYear W20171218442023 @default.
• W2017121844 crossrefType "journal-article" @default.
• W2017121844 hasAuthorship W2017121844A5024466338 @default.
• W2017121844 hasAuthorship W2017121844A5035481055 @default.
• W2017121844 hasAuthorship W2017121844A5039108879 @default.
• W2017121844 hasAuthorship W2017121844A5046463808 @default.
• W2017121844 hasAuthorship W2017121844A5047655376 @default.
• W2017121844 hasAuthorship W2017121844A5049492908 @default.
• W2017121844 hasAuthorship W2017121844A5051058664 @default.
• W2017121844 hasAuthorship W2017121844A5055865734 @default.
• W2017121844 hasBestOaLocation W20171218441 @default.
• W2017121844 hasConcept C141071460 @default.
• W2017121844 hasConcept C2776283816 @default.
• W2017121844 hasConcept C2776943423 @default.
• W2017121844 hasConcept C2777202286 @default.
• W2017121844 hasConcept C2777466421 @default.
• W2017121844 hasConcept C2779480337 @default.
• W2017121844 hasConcept C2781099653 @default.
• W2017121844 hasConcept C3018348675 @default.
• W2017121844 hasConcept C42219234 @default.
• W2017121844 hasConcept C71924100 @default.
• W2017121844 hasConceptScore W2017121844C141071460 @default.
• W2017121844 hasConceptScore W2017121844C2776283816 @default.
• W2017121844 hasConceptScore W2017121844C2776943423 @default.
• W2017121844 hasConceptScore W2017121844C2777202286 @default.
• W2017121844 hasConceptScore W2017121844C2777466421 @default.
• W2017121844 hasConceptScore W2017121844C2779480337 @default.
• W2017121844 hasConceptScore W2017121844C2781099653 @default.
• W2017121844 hasConceptScore W2017121844C3018348675 @default.
• W2017121844 hasConceptScore W2017121844C42219234 @default.
• W2017121844 hasConceptScore W2017121844C71924100 @default.
• W2017121844 hasIssue "6" @default.
• W2017121844 hasLocation W20171218441 @default.
• W2017121844 hasLocation W20171218442 @default.
• W2017121844 hasOpenAccess W2017121844 @default.
• W2017121844 hasPrimaryLocation W20171218441 @default.
• W2017121844 hasRelatedWork W1970729951 @default.
• W2017121844 hasRelatedWork W1976036258 @default.
• W2017121844 hasRelatedWork W2016073743 @default.
• W2017121844 hasRelatedWork W2017121844 @default.
• W2017121844 hasRelatedWork W2048095284 @default.
• W2017121844 hasRelatedWork W2072725660 @default.
• W2017121844 hasRelatedWork W2092280377 @default.

• next